The agreement provides Vizient’s network of healthcare providers with enhanced access to the Allergan Aesthetics breast implant line.
Allergan Aesthetics, an AbbVie company, announced that its Natrelle brand of breast implants has been named a supplier by Vizient, Inc, a provider-driven healthcare performance improvement company.
The agreement connects the Natrelle portfolio to Vizient’s network, which includes academic medical centers, community hospitals, integrated delivery networks, and non-acute care providers. Through the contract, Vizient clients will have access to Natrelle’s line of more than 300 implant options. According to Allergan Aesthetics, providers will also receive competitive pricing, a simplified procurement process, improved operational efficiency, and direct support from the brand’s sales and technical teams.
“This agreement with Vizient underscores our commitment to supporting women through their breast reconstruction journeys while equipping providers with the tools they need to deliver exceptional care,” says Glen Curran, senior vice president, US, Allergan Aesthetics, in a release. “We’re proud to offer Natrelle to Vizient’s clients and support their ongoing efforts in delivering personalized, patient-centered outcomes.”
ID 41398756 © Saicle | Dreamstime.com
